US Prostate Cancer Drug Market Outlook to 2026: Comprehensive Clinical Insight on 25 FDA Approved Prostate Cancer Drugs
10 févr. 2021 03h38 HE
|
Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Global Clinical Trial Management System Market (2020 to 2025) - Increasing Outsourcing of Research Processes Presents Opportunities
08 févr. 2021 07h18 HE
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise,...
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
05 févr. 2021 09h00 HE
|
Denali Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to...
Insights on the Cancer Biological Toxins Drug Global Market to 2026 - by Phase, Status, Cancer Type and Countries
04 févr. 2021 07h48 HE
|
Research and Markets
Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biological Toxins Drug Market Opportunity, Drug Sales & Clinical Trials Insight 2026" report has been added to...
Virtual Clinical Trials APAC Industry to 2026 - Featuring Dassault Systemes, Oracle and PRA Health Sciences Among Others
03 févr. 2021 06h08 HE
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Asia Pacific Virtual Clinical Trials Market By Study Type, By Indication, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been...
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
02 févr. 2021 07h30 HE
|
Mustang Bio, Inc.
FDA removes clinical hold for pivotal Phase 2 MB-107 clinical trial Company plans to enroll first patient in MB-107 pivotal trial in the second quarter of 2021 Clinical outcomes in investigator-IND...
Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to Begin Next Week
29 janv. 2021 09h15 HE
|
Innovation Pharmaceuticals Inc.
Brilacidin treatment unlikely to be impacted by coronavirus variants, such as those originating in the U.K., South Africa and Brazil, and spreading worldwide, due to its ability to attack the virus...
Life Line Screening accelerates its clinical research transformation by appointing Matthew Maxwell as Chief of Clinical Research Strategy.
29 janv. 2021 07h00 HE
|
Life Line Screening
Mr. Maxwell will be responsible for unlocking Life Line Screening’s distinctive ability to connect motivated patients to compelling clinical research opportunities. AUSTIN, Texas, Jan. 29, 2021 ...
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy
28 janv. 2021 09h20 HE
|
Asklepios BioPharmaceutical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned...
Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient
26 janv. 2021 08h00 HE
|
Inato SAS
The Inato Marketplace is Reinventing the Collaboration Model Between Clinical Trial Sponsors and Sites PARIS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Inato, the first global industry marketplace that...